Eloxx pharmaceuticals, inc. (ELOX)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11
ASSETS
Current assets:
Cash and cash equivalents

25,875

22,493

22,155

49,326

44,576

48,606

55,336

63,412

18,290

24,049

957

33

241

2,212

287

810

1,525

2,366

3,354

3,334

469

2,107

3,837

6,111

6,198

6,121

789

1,602

1,581

640

1,312

2,001

3,207

1,552

2,841

3,609

Marketable securities

18,082

33,783

42,781

26,973

8,928

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

43

43

40

45

45

45

46

100

106

102

-

-

-

38

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accounts receivable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

203

43

43

-

-

-

0

-

-

-

-

-

-

-

-

Prepaid expenses and other current assets

1,927

1,390

1,878

1,392

1,911

1,690

756

458

445

355

80

251

30

837

88

171

78

321

299

395

128

-

-

1,069

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid research supplies and expenses

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

62

163

-

1,199

1,488

1,566

1,919

1,712

1,295

1,459

1,548

1,735

1,657

1,824

1,446

Total current assets

45,927

57,709

66,854

77,736

55,460

50,341

56,138

63,970

18,841

24,506

1,038

284

272

3,087

375

982

1,603

2,687

3,654

3,729

598

2,373

4,043

7,224

7,397

7,610

2,355

3,521

3,293

1,935

2,771

3,549

4,942

3,210

4,666

5,056

Property and equipment, net

182

201

220

214

231

248

345

302

314

278

42

50

60

41

80

92

105

124

153

185

226

259

262

223

2

3

4

4

5

5

6

5

6

7

3

3

Operating lease right-of-use asset

822

924

870

989

1,106

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other long-term assets

110

113

113

100

94

129

52

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Patent costs, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

463

283

-

2,178

-

-

-

-

-

-

-

-

-

-

-

-

Patent costs, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

123

-

3,553

3,482

3,450

3,566

3,587

3,517

3,476

3,393

3,680

3,634

3,596

3,524

Acquired research and development

-

-

-

-

-

-

-

-

-

-

5,500

5,500

5,500

-

6,500

8,100

8,800

9,800

9,800

9,800

9,800

9,800

9,800

9,800

-

-

-

0

-

-

-

-

-

-

-

-

Goodwill

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

2,980

5,780

5,780

5,780

5,780

13,902

13,902

-

-

-

0

-

-

-

-

-

-

-

-

Deferred income tax assets, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

0

0

0

0

Security deposits

-

-

-

-

-

-

-

-

-

-

9

9

9

-

55

50

50

50

50

50

50

55

5

5

5

5

5

5

5

5

5

5

5

5

5

12

Total assets

47,041

58,947

68,057

79,039

56,891

50,718

56,535

64,272

19,155

24,784

6,591

5,845

5,842

3,128

7,012

9,225

10,559

15,643

19,439

19,547

16,919

18,553

28,137

33,334

10,959

11,101

5,814

7,097

6,891

5,463

6,260

6,954

8,634

6,857

8,271

8,596

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable

1,389

1,871

1,687

2,473

2,240

747

1,352

2,098

2,173

1,530

108

191

109

1,899

144

90

56

63

174

232

656

1,305

613

901

324

477

1,003

637

686

1,085

932

594

804

443

949

559

Accrued expenses

3,568

4,655

5,145

5,773

4,597

6,938

3,727

2,258

3,478

1,893

255

330

157

619

316

256

282

450

398

408

825

1,094

1,074

923

730

616

406

387

344

468

304

369

529

802

651

509

Current portion of long-term debt

4,772

4,336

3,488

2,231

984

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Advances from collaboration partners

805

403

403

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of operating lease liability

507

499

461

473

481

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Taxes payable

43

43

43

43

122

122

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Notes Payable

-

-

-

-

-

-

-

-

-

-

712

407

256

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Derivative Liability

-

-

-

-

-

-

-

-

-

-

0

1,844

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Derivative liability

-

-

-

-

-

-

-

-

-

-

-

-

533

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other current liabilities

-

-

-

-

-

-

-

-

-

-

-

-

0

-

6

22

38

54

102

137

173

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

150

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Line of credit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

2,187

2,187

2,187

2,187

2,199

2,199

2,199

2,199

2,199

2,199

2,199

Total current liabilities

11,084

11,807

11,227

10,993

8,424

7,807

5,079

4,356

5,651

3,423

1,076

2,773

1,057

2,518

467

368

377

569

675

778

1,655

2,549

1,687

1,825

1,055

3,281

3,597

3,211

3,218

3,752

3,436

3,163

3,532

3,445

3,799

3,268

Long-term debt

9,385

10,502

11,193

12,306

13,409

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liability

315

425

409

516

625

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Warrant and stock right liabilities

-

-

-

-

-

-

-

-

-

-

-

-

0

-

319

956

920

2,330

2,233

2,502

-

-

-

0

-

-

-

-

261

30

94

238

402

478

439

711

Deferred tax liability

-

-

-

-

-

-

-

-

-

-

2,200

2,200

2,200

-

2,600

3,240

3,520

3,920

3,920

3,920

3,920

3,920

-

3,920

-

-

-

-

-

-

-

-

-

-

-

-

Deferred rent

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

45

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred tax liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,920

-

-

-

-

0

-

-

-

-

-

-

-

-

Other liabilities

-

-

-

-

-

-

-

-

-

-

-

-

0

-

0

99

99

99

105

122

138

99

99

99

99

99

99

99

99

99

99

99

99

99

99

99

Total liabilities

20,784

22,734

-

-

-

7,807

-

-

-

-

3,276

4,973

3,257

-

3,386

4,665

4,917

6,919

6,934

7,322

5,713

6,614

5,706

5,844

1,155

3,381

3,697

3,311

3,580

3,882

3,630

3,501

4,035

4,023

4,338

4,079

Commitments and contingencies

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

0

-

0

0

0

0

-

-

-

0

-

-

-

-

Stockholders’ equity:
Preferred stock, $0.01 par value per share, 5,000,000 shares authorized, no shares issued or outstanding as of March 31, 2020 and December 31, 2019

-

-

-

-

-

-

0

0

0

-

-

-

-

76

-

-

-

-

-

-

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

Common stock, $0.01 par value per share, 500,000,000 shares authorized, 40,316,034 and 40,186,469 shares issued and 40,125,454 and 40,030,763 shares outstanding as of March 31, 2020 and December 31, 2019, respectively

403

402

404

402

361

360

351

349

274

274

514

292

269

42

204

204

204

204

203

187

139

138

138

138

68

49

23

22

1,469

1,169

1,167

941

918

808

796

777

Common stock in treasury, at cost, 190,580 and 155,706 shares as of March 31, 2020 and December 31, 2019, respectively

1,819

1,703

1,585

1,539

1,250

1,129

83

83

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Additional paid-in capital

178,573

174,515

171,783

168,848

133,383

129,825

123,306

120,607

60,782

60,047

-

-

-

18,238

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated other comprehensive income

65

18

12

24

1

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Capital in excess of par

-

-

-

-

-

-

-

-

-

-

126,006

122,401

121,767

-

119,991

119,983

119,905

119,899

119,810

119,217

116,545

116,042

115,770

115,631

92,631

85,542

78,325

78,189

74,272

71,855

71,611

69,952

69,511

66,376

65,832

64,488

Accumulated deficit

-150,965

-137,019

-125,386

-112,511

-98,062

-86,145

-72,118

-60,957

-47,552

-38,960

-123,205

-121,824

-119,453

-17,746

-116,573

-115,630

-

-

-

-107,182

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated deficit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

114,470

111,381

107,512

-

-

-

-

88,280

-

-

-

-

-

-

-

-

-

-

-

-

Accumulated deficit

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

105,478

104,242

93,478

-

82,896

77,872

76,231

74,425

72,430

71,443

70,149

67,440

65,831

64,351

62,696

60,748

Total stockholders’ equity

26,257

36,213

45,228

55,224

34,433

42,911

51,456

59,916

13,504

21,361

3,314

871

2,584

610

3,625

4,560

5,642

8,724

12,505

12,224

11,205

11,939

22,430

27,489

9,804

7,720

2,117

3,786

3,311

1,580

2,629

3,453

4,599

2,833

3,933

4,517

Total liabilities and stockholders’ equity

47,041

58,947

68,057

79,039

56,891

50,718

56,535

64,272

19,155

24,784

6,591

5,845

5,842

3,128

7,012

9,225

10,559

15,643

19,439

19,547

16,919

18,553

28,137

33,334

10,959

11,101

5,814

7,097

6,891

5,463

6,260

6,954

8,634

6,857

8,271

8,596